Characterization and treatment of daratumumab-associated infections in patients with multiple myeloma. Read more
Impact of novel salvage regimens in patients with relapsed/refractory primary mediastinal B-cell lymphoma prior to autologous stem cell transplant Read more
Transcriptional Profiles of CD19 Chimeric Antigen Receptor (CAR) T-cells that Induce Durable Remission in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Read more
A Phase 1b/2, Open-Label, Safety and Efficacy Study of Epcoritamab (GEN3013; DuoBody®-CD3 X CD20) in Relapsed/Refractory Chronic Lymphocytic Leukemia Read more
“Clinico-genomic Predictors of Outcomes Among Patients with HIV or Paraneoplastic Syndromes and Cancer” Read more
An Adaptive Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in Subjects with High-Risk Large B-Cell Lymphoma (ZUMA-23) Read more
